Jump to content

meta-Hydroxynorephedrine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 17:56, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Meta-Hydroxynorephedrine
Clinical data
Other namesm-hydroxypropadrine
m-hydroxyphenylpropanolamine
α-methyl-m-octopamine
3,β-dihydroxyamphetamine
3,β-dihydroxy-α-methylphenethylamine
ATC code
  • None
Legal status
Legal status
  • In general: non-regulated
Identifiers
  • 3-(2-amino-1-hydroxypropyl)phenol
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC9H13NO2
Molar mass167.205 g/mol g·mol−1
3D model (JSmol)
  • OC(c1cc(O)ccc1)C(N)C
  • InChI=1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3
  • Key:WXFIGDLSSYIKKV-UHFFFAOYSA-N

meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.[1][2] It is the racemic form of the sympathomimetic drug metaraminol.

See also

References

  1. ^ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 106. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.
  2. ^ Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. p. 2110. ISBN 978-0-8155-1526-5. Retrieved 24 April 2012.